Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Ono Pharmaceutical
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
urelumab
(BMS-663513) / BMS, Ono Pharmaceutical
lirilumab
(BMS-986015) / Innate, BMS, Ono Pharma
cabiralizumab
(BMS-986227) / Ono Pharmaceutical, BMS
BMS-986310
/ BMS
eltanexor
(KPT-8602) / Karyopharm
imzokitug
(BMS-986340) / BMS
atamparib
(RBN-2397) / Nerviano Medical Sciences
renvistobart
(BMS-986207) / BMS
Cereact
(arundic acid) / Ono Pharma
ONO-2952
/ Ono Pharma
ONO-4053
/ Ono Pharma
gemilukast
(ONO-6950) / Ono Pharma
inlexisertib
(DCC-3116) / Deciphera Pharmaceuticals
rebastinib
(DCC-2036) / Ono Pharmaceutical
tamnorzatinib
(ONO-7475) / Ono Pharma
ONO-2020
/ Ono Pharmaceutical
ONO-8539
/ Ono Pharma
eribulin liposomal
(E7389-LF) / Eisai, Ono Pharmaceutical
ipilimumab subcutaneous
(BMS-734016 SC) / Ono Pharma, BMS
DCC-3084
/ Ono Pharma
ONO-2808
/ Ono Pharmaceutical
ONO-4474
/ Ono Pharma
ONO-7579
/ Ono Pharma
salirasib
(KD 032) / Ono Pharmaceutical, Sanofi
Joyclu
(diclofenac etalhyaluronate) / Seikagaku, Ono Pharma, Eisai
ONO-7807
/ BMS, Ono Pharmaceutical
